Phase 2 Hyper-CVAD/Rituximab for Untreated Mantle Cell Lymphoma

Clinical trial NCT00581854 · COMPLETED

Trial details

NCT number: NCT00581854
Sponsor: University of Wisconsin, Madison
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mantle Cell Lymphoma

Start date: 2000-06-01
Primary completion: 2006-06-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.